KIAA1199 expression and hyaluronan degradation colocalize in multiple sclerosis lesions.
Saved in:
| Title: | KIAA1199 expression and hyaluronan degradation colocalize in multiple sclerosis lesions. |
|---|---|
| Authors: | Marella M; Drug Discovery Department, Halozyme Therapeutics, Inc., San Diego, CA, USA., Jadin L; Drug Discovery Department, Halozyme Therapeutics, Inc., San Diego, CA, USA., Keller GA; Drug Discovery Department, Halozyme Therapeutics, Inc., San Diego, CA, USA., Sugarman BJ; Drug Discovery Department, Halozyme Therapeutics, Inc., San Diego, CA, USA., Frost GI; F1 Oncology, West Palm Beach, FL, USA., Shepard HM; Drug Discovery Department, Halozyme Therapeutics, Inc., San Diego, CA, USA.; Biologics21.NET Consulting, San Diego, CA, USA. |
| Source: | Glycobiology [Glycobiology] 2018 Dec 01; Vol. 28 (12), pp. 958-967. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: IRL Press at Oxford University Press Country of Publication: England NLM ID: 9104124 Publication Model: Print Cited Medium: Internet ISSN: 1460-2423 (Electronic) Linking ISSN: 09596658 NLM ISO Abbreviation: Glycobiology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1460-2423 |
|---|---|
| DOI: | 10.1093/glycob/cwy064 |
